153 related articles for article (PubMed ID: 31911119)
1. An efficient, reproducible and accurate RT-qPCR based method to determine mumps specific neutralizing antibody.
Sikazwe CT; Levy A; Speers D; Smith DW
J Virol Methods; 2020 Mar; 277():113817. PubMed ID: 31911119
[TBL] [Abstract][Full Text] [Related]
2. Assessment of one-dose mumps-containing vaccine effectiveness on wild-type genotype F mumps viruses circulating in mainland China.
Cui A; Zhu Z; Mao N; Si Y; Ma Y; Hu Y; Deng X; Wang L; Zeng L; Zhang Y; Xu W
Vaccine; 2018 Sep; 36(38):5725-5731. PubMed ID: 30122648
[TBL] [Abstract][Full Text] [Related]
3. Mumps vaccine failure investigation in Novosibirsk, Russia, 2002-2004.
Atrasheuskaya AV; Kulak MV; Rubin S; Ignatyev GM
Clin Microbiol Infect; 2007 Jul; 13(7):670-6. PubMed ID: 17484765
[TBL] [Abstract][Full Text] [Related]
4. A new method for the detection of neutralizing antibodies against mumps virus.
Matsubara K; Fujino M; Takeuchi K; Iwata S; Nakayama T
PLoS One; 2013; 8(7):e65281. PubMed ID: 23861738
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of mumps virus vaccine candidates matching circulating genotypes in the United States and China.
Zengel J; Phan SI; Pickar A; Xu P; He B
Vaccine; 2017 Jul; 35(32):3988-3994. PubMed ID: 28623030
[TBL] [Abstract][Full Text] [Related]
6. Mumps outbreaks in a highly vaccinated population: Investigation of a neutralization titre against the current circulating wildtype genotype G5 mumps virus.
Kenny L; O'Kelly E; Connell J; De Gascun C; Hassan J
J Clin Virol; 2016 Jan; 74():8-12. PubMed ID: 26630067
[TBL] [Abstract][Full Text] [Related]
7. Investigation of mumps vaccine failures in Minsk, Belarus, 2001-2003.
Atrasheuskaya AV; Blatun EM; Kulak MV; Atrasheuskaya A; Karpov IA; Rubin S; Ignatyev GM
Vaccine; 2007 Jun; 25(24):4651-8. PubMed ID: 17498853
[TBL] [Abstract][Full Text] [Related]
8. Sera from different age cohorts in Belgium show limited cross-neutralization between the mumps vaccine and outbreak strains.
Vermeire T; Barbezange C; Francart A; Hamouda A; Litzroth A; Hutse V; Martens L; Vandermarliere E; Van Gucht S
Clin Microbiol Infect; 2019 Jul; 25(7):907.e1-907.e6. PubMed ID: 30502489
[TBL] [Abstract][Full Text] [Related]
9. [The benefit from mumps virus IgG antibody avidity testing in the population with high vaccine coverage in the context of other serological methods for laboratory diagnosis of mumps and the current epidemiological].
Limberková R; Smíšková D; Havlíčková M; Herrmannová K; Lexová P; Marešová V
Epidemiol Mikrobiol Imunol; 2016; 65(1):39-44. PubMed ID: 27246643
[TBL] [Abstract][Full Text] [Related]
10. Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection.
Gouma S; Ten Hulscher HI; Schurink-van 't Klooster TM; de Melker HE; Boland GJ; Kaaijk P; van Els CACM; Koopmans MPG; van Binnendijk RS
Vaccine; 2016 Jul; 34(35):4166-4171. PubMed ID: 27372154
[TBL] [Abstract][Full Text] [Related]
11. [Virus strain specific serum neutralizing antibodies in children and adolescents immunized with a Russian mumps vaccine].
Otrashevskaia EV; Krasil'nikov IV; Ignat'ev GM
Vopr Virusol; 2010; 55(6):15-9. PubMed ID: 21381334
[TBL] [Abstract][Full Text] [Related]
12. Identification and development of a promising novel mumps vaccine candidate strain.
Liang Y; Ma S; Liu L; Zhao H; Wang L; Jiang L; Xie Z; Dong C; Li Q
Microbes Infect; 2010 Dec; 12(14-15):1178-87. PubMed ID: 20800105
[TBL] [Abstract][Full Text] [Related]
13. Development of a focus reduction neutralization test (FRNT) for detection of mumps virus neutralizing antibodies.
Vaidya SR; Brown DW; Jin L; Samuel D; Andrews N; Brown KE
J Virol Methods; 2010 Jan; 163(1):153-6. PubMed ID: 19761798
[TBL] [Abstract][Full Text] [Related]
14. RT-qPCR-based microneutralization assay for human cytomegalovirus using fibroblasts and epithelial cells.
Wang X; Peden K; Murata H
Vaccine; 2015 Dec; 33(51):7254-7261. PubMed ID: 26552003
[TBL] [Abstract][Full Text] [Related]
15. [Functional state of specific immunity in children and teenagers vaccinated against mumps].
Otrashevskaia EV; Bukin EK; Krasil'nikov IV; Ignat'ev GM
Vopr Virusol; 2010; 55(4):20-5. PubMed ID: 20886708
[TBL] [Abstract][Full Text] [Related]
16. Utility of neutralization test for laboratory diagnosis of suspected mumps.
Vaidya SR; Hamde VS; Kumbhar NS; Walimbe AM
Microbiol Immunol; 2018 Apr; 62(4):243-247. PubMed ID: 29363797
[TBL] [Abstract][Full Text] [Related]
17. Virus genotypes and responses of serum-specific antibodies in children with primary mumps and mumps reinfection.
Sakata R; Nagita A; Kidokoro M; Kato A; Ogino K
Pediatr Res; 2015 Nov; 78(5):580-4. PubMed ID: 26267156
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of the serologic response in vaccinated and unvaccinated mumps cases during an epidemic.
Kaaijk P; Gouma S; Hulscher HI; Han WG; Kleijne DE; van Binnendijk RS; van Els CA
Hum Vaccin Immunother; 2015; 11(7):1754-61. PubMed ID: 26047038
[TBL] [Abstract][Full Text] [Related]
19. Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays.
Mauldin J; Carbone K; Hsu H; Yolken R; Rubin S
J Clin Microbiol; 2005 Sep; 43(9):4847-51. PubMed ID: 16145156
[TBL] [Abstract][Full Text] [Related]
20. Detection of measles, mumps and rubella viruses by immuno-colorimetric assay and its application in focus reduction neutralization tests.
Vaidya SR; Kumbhar NS; Bhide VS
Microbiol Immunol; 2014 Dec; 58(12):666-74. PubMed ID: 25244651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
